BG Medicine, Inc. develops and markets diagnostic tests. The Company develops biomarkers that predict a patient's response to a drug therapy, determine the potential toxicity of therapeutic agents to patients, identify patients who have or are likely to develop a specific disease, predict a patient's prognosis once a disease has been diagnosed, and monitor a patient's disease progression.
Insider Trading Cheat Sheet
No insider trading data available for BG Medicine, Inc..
Wall St. Cheat Sheet has been featured in these fine media outlets: